SEC Filing Summary

Mark Leonard Singleton, SVP & CFO of Bioventus Inc., reported several transactions on March 13, 2026. He acquired 13,500 shares of Class A Common Stock with a transaction price of $0.00, bringing his post-transaction shares to 165,312. Subsequently, he disposed of 5,865 shares of Class A Common Stock at a price of $8.62 per share, resulting in 159,447 shares remaining. Additionally, Singleton was granted 104,000 Restricted Stock Units (RSUs) and 116,000 Stock Options (Right to Buy) on March 13, 2026, with vesting over four years. He also acquired 54,000 RSUs and 61,000 Stock Options on March 14, 2025, also subject to a four-year vesting schedule. A prior disposition of 13,500 RSUs was also noted on March 13, 2026, leaving him with 40,500 RSUs.